TuesdayMar 26, 2019 11:56 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Revolutionary Technology is Disrupting the Cannabis Edibles Industry

Lexaria Bioscience Corp. is the only company worldwide with patents issued for oral delivery of all cannabinoids Its proprietary technology bests traditional methods such as inhalation in several key ways The company continues to enhance its intellectual property portfolio as it pursues patents around the world Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a food biosciences company, has developed a proprietary technology that has revolutionized the way cannabidiol (CBD) and other non-psychoactive cannabinoids are delivered into the bloodstream. Lexaria, the only company worldwide with patents issued for oral delivery of all cannabinoids, has greatly improved the delivery of bioactive compounds.…

Continue Reading

TuesdayMar 12, 2019 12:31 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Innovating on Numerous Fronts with DehydraTECH Drug Delivery Platform

Lexaria Bioscience is focusing on its unique technology for the delivery of bioactive compounds The company’s concentration on oral ingestion results in an option that often healthier than other delivery methods Its DehydraTECH technology has potential applications for nicotine absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Its DehydraTECH drug delivery platform fosters healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules. The company’s process changes the way edible cannabinoids enter the body (http://cnw.fm/s5uPI). A drug delivery innovator, Lexaria Bioscience is headquartered in Kelowna,…

Continue Reading

FridayMar 01, 2019 12:53 pm

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Does Not Irradiate its Cannabis; 80 Percent of LPs Do

Clean, controlled cultivation eschews use of radiation to destroy pests and pathogens Analysts at Jefferies recently initiated coverage of FLWR Flowr has applied for Nasdaq Listing The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) is growing cannabis with TLC as well as THC. The Health Canada Licensed Producer (“LP”) of cannabis, founded by MedReleaf co-founder Tom Flow and a team of industry pioneers, is out to generate premium, non-irradiated product at high yields. The company expects its ability to produce clean cannabis at consistently high quality to be a crucial differentiating factor as the medical and recreational markets in Canada develop. Its…

Continue Reading

FridayMar 01, 2019 11:13 am

Marijuana Company of America Inc.’s (MCOA) High-Yielding Hemp Projects Blossom as ‘Green Industry’ Set to Thrive in 2019

Global hemp retail sales totaled $3.7 billion in 2018, on track to reach $5.7 billion by 2020 2018 Farm Bill legalizing hemp, CBD-based products, now allows farmers to plant industrial hemp nationwide Cultivation of hemp at Scio, Oregon, project site to begin in early 2019 for an extended growing season MCOA’s wholly owned subsidiary, hempSMART, brings high quality, branded CBD-based products to consumers through an affiliate marketing program Market opportunities for the hemp-based cannabidiol (“CBD”) product industry in the U.S. are many and growing now that hemp is legally protected following passage of the 2018 Farm Bill in December. Innovative…

Continue Reading

ThursdayFeb 14, 2019 1:53 pm

Marijuana Company of America Inc. (MCOA) Promotes Brand During Super Bowl and Hollywood Events

February events have and will continue to provide the company with opportunities to increase its recognition amid Super Bowl and pre-Academy Awards gatherings Marijuana Company of America Inc. upgraded its market tier to the OTCQB Venture Exchange in December The company is aggressively pursuing a strategy of building a following for its hemp products by marketing to celebrities and pro athletes Amid the rise of the cannabis industry and the high degree of attention that consumers and investors alike are paying to the varied applications of the plant and its derivatives, Marijuana Company of America Inc. (OTCQB: MCOA) is raising…

Continue Reading

MondayFeb 11, 2019 11:21 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Creates Unique Opportunity in Global Cannabis Industry

Big corporations are investing in the cannabis industry Major tobacco company provides financing for LXRP LXRP boasts revenue streams within the nicotine industry and opportunity in other sectors Lexaria is a unique company doing business on its own terms The cannabis industry is experiencing impressive growth thanks to both legal and social changes worldwide, and big corporations are stepping up to invest. In a new Audio Press Release (“APR”), PsychedelicNewsAudio praised Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (http://cnw.fm/Ap2N5) for building a large funding deal on its own terms. The APR, ‘Outside Investment, New Technology Support Growing Cannabis Industry’, highlighted Lexaria’s ability…

Continue Reading

ThursdayJan 24, 2019 11:37 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Acquires a $12 Million Investor

Lexaria Nicotine LLC partners with one of the world’s largest tobacco companies Opportunity to change nicotine delivery and improve the lives of millions Retains ownership of DehydraTECH while licensing the technology out to multiple industries Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced that its wholly owned subsidiary, Lexaria Nicotine LLC, has partnered with one of the world’s largest tobacco companies to fund the research and development of Lexaria’s patented DehydraTECH (http://cnw.fm/w86Vf). The partnership may potentially commercialize this cutting-edge technology for oral nicotine delivery. Chris Bunka, CEO of Lexaria Bioscience, is excited about the opportunity to work with a world-class…

Continue Reading

FridayJan 11, 2019 11:10 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Discusses Company Initiatives at O’Cannabiz 2018

Lexaria Bioscience has its innovative DehydraTECH drug delivery platform The company’s DehydraTECH technology is complementary to other R&D being done on cannabinoids Lexaria recently attended O’Cannabiz 2018 in Vancouver A biotech company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) offers a unique platform that makes it possible to deliver bioactive substances through oral ingestion. Its DehydraTECH technology accomplishes this without the need for unhealthy inhalational dosing. DehydraTECH uses only GRAS (Generally Recognized as Safe) ingredients and increases bio-absorption by five to 10 times. Based in Kelowna, British Columbia, Lexaria Bioscience is the only company globally with patents issued for the…

Continue Reading

TuesdayDec 04, 2018 11:27 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Submits Application for Research License to Health Canada

Lexaria has developed its DehydraTECH technology The company also has four new subsidiaries Lexaria recently submitted its application to Health Canada for a research license Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses its DehydraTECH technology – a drug delivery platform. It is the only company globally with a patent issued for oral delivery of all cannabinoids. The company’s technology facilitates the delivery of bioactive substances via oral ingestion without the need for inhalational dosing or co-administration with sugars or sweeteners. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has four…

Continue Reading

TuesdayDec 04, 2018 11:06 am

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Keeps its Vision High as Cannabis Prospects Continue to Germinate through Political Changes

U.S. midterm elections signal growing fortunes for cannabis industries with pro-cannabis voting, ouster of anti-cannabis attorney general Phivida among cannabis industry companies that enjoy stock boost in immediate wake of elections Phivida enthused by new FDA and DEA acceptance of natural cannabis in pharmaceuticals, which opens prospects for non-FDA administered products as well Company announces appointment of new senior vice president of distribution to optimize placement of its products in functional food and beverage markets A rolling groundswell of progressive developments in the cannabis use seascape, driven by winds of change in North America’s political arenas, is underscoring the optimism…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000